0001209191-15-032090.txt : 20150403
0001209191-15-032090.hdr.sgml : 20150403
20150403115340
ACCESSION NUMBER: 0001209191-15-032090
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150402
FILED AS OF DATE: 20150403
DATE AS OF CHANGE: 20150403
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: bluebird bio, Inc.
CENTRAL INDEX KEY: 0001293971
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 SECOND STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: 339-499-9300
MAIL ADDRESS:
STREET 1: 150 SECOND STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
FORMER COMPANY:
FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc
DATE OF NAME CHANGE: 20040616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Eric
CENTRAL INDEX KEY: 0001601797
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35966
FILM NUMBER: 15750592
MAIL ADDRESS:
STREET 1: GOODWIN PROCTER LLP
STREET 2: 53 STATE ST
CITY: BOSTON
STATE: MA
ZIP: 02109
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-04-02
0
0001293971
bluebird bio, Inc.
BLUE
0001601797
Sullivan Eric
C/O BLUEBIRD BIO, INC.
150 SECOND STREET
CAMBRIDGE
MA
02141
0
1
0
0
Principal Accounting Officer
Common Stock
2015-04-02
4
M
0
750
20.70
A
1066
D
Common Stock
2015-04-02
4
M
0
2248
24.47
A
3314
D
Common Stock
2015-04-02
4
S
0
1993
117.3102
D
1321
D
Common Stock
2015-04-02
4
S
0
805
118.5722
D
516
D
Common Stock
2015-04-02
4
S
0
200
119.7241
D
316
D
Stock Options (right to buy)
20.70
2015-04-02
4
M
0
750
0.00
D
2023-12-02
Common Stock
3500
7750
D
Stock Option (right to buy)
24.47
2015-04-02
4
M
0
2248
0.00
D
2024-03-03
Common Stock
2248
5502
D
The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 5, 2015.
The range in prices for the transaction reported on this line was $117.00 to $117.8600. The average weighted price was $117.3102. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The range in prices for the transaction reported on this line was $118.11 to $118.93. The average weighted price was $118.5722. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The range in prices for the transaction reported on this line was $119.40 to $120.11. The average weighted price was $119.7241. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
This option vests over a four-year period, at a rate of twenty-five percent(25%) on November 11, 2014 and in 36 equal monthly installments thereafter.
This option vests over a four-year period, at a rate of twenty-five percent(25%) on January 1, 2015 and in 36 equal monthly installments thereafter.
/s/ Jason F. Cole, Attorney-in-Fact
2015-04-03